Topic: Synthes Inc.

Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results

Drugs.com - 24 days ago
Tweet . 2011 Fourth-Quarter Sales of $16.3 Billion Increased 3.9%; EPS was $0.08 2011 Full-Year Sales of $65.0 Billion Increased 5.6%; Full-Year...

Johnson & Johnson's Q4 Earnings Show Much Work Remains For Management

SeekingAlpha - 25 days ago
Going into this earnings release cycle, the growth expectations for med-tech companies like Johnson & Johnson (JNJ) were already pretty modest...

Ex-execs get 9 months for fatal bone cement trial

San Francisco Chronicle - 89 days ago
0 . Three former executives of a Pennsylvania medical devices company have been sentenced to prison for unapproved medical trials that left three ...

Abbott Breakup Follows Familiar Pattern

SeekingAlpha - 121 days ago
News that Abbott Labs (ABT) will divide itself into separate drug and medical device companies follows a familiar pattern that has proven highly...

Johnson & Johnson Brought Down By The Market

SeekingAlpha - 122 days ago
Johnson & Johnson (JNJ) is a pharmaceutical holding company. With more than 250 subsidiary companies and 139 medical manufacturing centers, Johnson...

Synthes 3Q Sales Rise 11% To Top $1 Billion For First Time

FOX Business - 122 days ago
Synthes Inc. (SYST. VX) Wednesday reported an 11% increase in third-quarter sales, posting its first quarterly billion-dollar milestone. . . MAIN...

Johnson & Johnson Q2 Earnings Beat Analyst Expectations

American Banking News - 213 days ago
Johnson Johnson (NYSE:JNJ) reported Q2 EPS of $1.28, ex-items, better than analyst estimates of $1.23. Revenue for the quarter rose 8.3%...

US doctors face sanctions for spine study payments

Reuters US Online Report Health News - 290 days ago
CHICAGO (Reuters) - New Jersey's physician regulatory board has disciplined three orthopedic surgeons for failing to disclose financial interests in an artificial spinal disc made by Swiss medical device maker Synthes Inc .The New Jersey Board of Medical Examiners reprimanded Thomas Errico ...

J&J strikes $21 bn takeover deal for Synthes

AFP Global Edition - 297 days ago
US health care giant Johnson & Johnson announced on Wednesday an agreement on a $21.3-billion takeover of US-Swiss medical technology company Synthes in one of the biggest deals so far this year.The two companies "announced that they have entered into a ...

J&J to buy device maker Synthes for over $21 billion

Reuters US Online Report Health News - 297 days ago
ZURICH/NEW YORK (Reuters) - Johnson & Johnson will buy Swiss medical devices maker Synthes Inc for $21.67 billion, placing a big bet on growing its orthopedics business with one of the largest deals ever in the medical technology sector.The acquisition is ...